Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
4538.T
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+5%
54.16
vs 51.52
Q1.23
+1034%
12.77
vs -1.37
Q2.23
-14%
54.62
vs 63.73
Q3.23
-48%
27.29
vs 52.33
Q4.23
+11%
60.27
vs 54.16
Q1.24
+39%
17.72
vs 12.77
Q2.24
+35%
73.97
vs 54.62
Q3.24
+287%
105.71
vs 27.29
Q4.24
+68%
101.5
vs 60.27
Q1.25
+150%
44.27
vs 17.72
Sales Growth
YoY
Current
Estimates
Q4.22
+4%
13.8B vs 13.3B
Q1.23
+4%
11.8B vs 11.4B
Q2.23
+9%
13.5B vs 12.4B
Q3.23
+7%
13.9B vs 13B
Q4.23
+11%
15.4B vs 13.8B
Q1.24
+7%
12.6B vs 11.8B
Q2.24
+8%
14.6B vs 13.5B
Q3.24
+9%
15.1B vs 13.9B
Q4.24
+10%
16.9B vs 15.4B
Q1.25
+11%
13.9B vs 12.6B
Return on Equity
QoQ
Q2.23
+1%
0.01
vs 0
Q3.23
+1%
0.01
vs 0.01
Q4.23
+1%
0.01
vs 0.01
Q1.24
+0%
0
vs 0.01
Q2.24
+2%
0.02
vs 0
Q3.24
+2%
0.02
vs 0.02
Q4.24
+2%
0.02
vs 0.02
Q1.25
+1%
0.01
vs 0.02
Institutionnal Ownership
Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceutical products in Japan. The company offers ethical drugs, such as injectables and artificial kidney dialysates; and medical machinery and equipment. It also rents real estate properties. The company was founded in 1937 and is headquartered in Osaka, Japan.
JPX
14.00Â ( 0.66%)
Relative Strenght
Volume Buzz
-60%
Earning Acce
No
Dist 52w H.
26%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 4538.T compares to sector?